Verastem Inc
NASDAQ:VSTM
Verastem Inc
NASDAQ:VSTM
Price:
11.92 USD
4.56%
Updated:
May 10, 2024
Verastem Inc
EPS (Diluted)
|
Verastem Inc
EPS (Diluted) Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Verastem Inc
NASDAQ:VSTM
|
EPS (Diluted)
-$3
|
CAGR 3-Years
9%
|
CAGR 5-Years
22%
|
CAGR 10-Years
15%
|
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$2
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$0
|
CAGR 3-Years
18%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-18%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$7
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$13
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$33
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
25%
|
See Also
What is Verastem Inc's EPS (Diluted)?
EPS (Diluted)
-4
USD
-4
USD
Based on the financial report for Dec 31, 2023, Verastem Inc's EPS (Diluted) amounts to -4 USD.
What is Verastem Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
15%
15%
Over the last year, the EPS (Diluted) growth was 13%. The average annual EPS (Diluted) growth rates for Verastem Inc have been 9% over the past three years , 22% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
